35 results on '"Wigner, Paulina"'
Search Results
2. Oxidative stress parameters as biomarkers of bladder cancer development and progression
- Author
-
Wigner, Paulina, Szymańska, Beata, Bijak, Michał, Sawicka, Ewa, Kowal, Paweł, Marchewka, Zofia, and Saluk-Bijak, Joanna
- Published
- 2021
- Full Text
- View/download PDF
3. Doxorubicin–transferrin conjugate alters mitochondrial homeostasis and energy metabolism in human breast cancer cells
- Author
-
Wigner, Paulina, Zielinski, Krzysztof, Labieniec-Watala, Magdalena, Marczak, Agnieszka, and Szwed, Marzena
- Published
- 2021
- Full Text
- View/download PDF
4. Disturbance of cellular homeostasis as a molecular risk evaluation of human endothelial cells exposed to nanoparticles
- Author
-
Wigner, Paulina, Zielinski, Krzysztof, Michlewska, Sylwia, Danielska, Paulina, Marczak, Agnieszka, Ricci, Eduardo Junior, Santos-Oliveira, Ralph, and Szwed, Marzena
- Published
- 2021
- Full Text
- View/download PDF
5. The Effect of Chronic Mild Stress and Venlafaxine on the Expression and Methylation Levels of Genes Involved in the Tryptophan Catabolites Pathway in the Blood and Brain Structures of Rats
- Author
-
Wigner, Paulina, Synowiec, Ewelina, Jóźwiak, Paweł, Czarny, Piotr, Bijak, Michał, Białek, Katarzyna, Szemraj, Janusz, Gruca, Piotr, Papp, Mariusz, and Śliwiński, Tomasz
- Published
- 2020
- Full Text
- View/download PDF
6. Preliminary Study of the Impact of Single-Nucleotide Polymorphisms of IL-1α, IL-1β and TNF-α Genes on the Occurrence, Severity and Treatment Effectiveness of the Major Depressive Disorder
- Author
-
Bialek, Katarzyna, Czarny, Piotr, Watala, Cezary, Synowiec, Ewelina, Wigner, Paulina, Bijak, Michal, Talarowska, Monika, Galecki, Piotr, Szemraj, Janusz, and Sliwinski, Tomasz
- Published
- 2020
- Full Text
- View/download PDF
7. The molecular aspects of oxidative & nitrosative stress and the tryptophan catabolites pathway (TRYCATs) as potential causes of depression
- Author
-
Wigner, Paulina, Czarny, Piotr, Galecki, Piotr, Su, Kuan-Pin, and Sliwinski, Tomasz
- Published
- 2018
- Full Text
- View/download PDF
8. Ethylene glycol dimethacrylate and diethylene glycol dimethacrylate exhibits cytotoxic and genotoxic effect on human gingival fibroblasts via induction of reactive oxygen species
- Author
-
Bielecka-Kowalska, Anna, Czarny, Piotr, Wigner, Paulina, Synowiec, Ewelina, Kowalski, Bartosz, Szwed, Marzena, Krupa, Renata, Toma, Monika, Drzewiecka, Malgorzata, Majsterek, Ireneusz, Szemraj, Janusz, Sliwinski, Tomasz, and Kowalski, Michał
- Published
- 2018
- Full Text
- View/download PDF
9. The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression
- Author
-
Czarny, Piotr, Wigner, Paulina, Galecki, Piotr, and Sliwinski, Tomasz
- Published
- 2018
- Full Text
- View/download PDF
10. Decreased expression level of BER genes in Alzheimer's disease patients is not derivative of their DNA methylation status
- Author
-
Sliwinska, Agnieszka, Sitarek, Przemysław, Toma, Monika, Czarny, Piotr, Synowiec, Ewelina, Krupa, Renata, Wigner, Paulina, Bialek, Katarzyna, Kwiatkowski, Dominik, Korycinska, Anna, Majsterek, Ireneusz, Szemraj, Janusz, Galecki, Piotr, and Sliwinski, Tomasz
- Published
- 2017
- Full Text
- View/download PDF
11. Association between single nucleotide polymorphisms of TPH1 and TPH2 genes, and depressive disorders
- Author
-
Wigner, Paulina, Czarny, Piotr, Synowiec, Ewelina, Bijak, Michał, Białek, Katarzyna, Talarowska, Monika, Galecki, Piotr, Szemraj, Janusz, and Sliwinski, Tomasz
- Published
- 2018
- Full Text
- View/download PDF
12. Variability, Expression, and Methylation of IL-6 and IL-8 Genes in Bladder Cancer Pathophysiology.
- Author
-
Grębowski, Radosław, Saluk, Joanna, Bijak, Michał, Szemraj, Janusz, and Wigner, Paulina
- Subjects
GENE expression ,CANCER genes ,BLADDER cancer ,INTERLEUKIN-6 ,PATHOLOGICAL physiology ,SINGLE nucleotide polymorphisms ,P16 gene - Abstract
Bladder cancer (BC) is the 10th most common form of cancer globally, but its complete aetiology is still unknown. Nevertheless, there is evidence that chronic inflammation plays a role in the development and progression of BC. Therefore, the presented study aimed to detect a potential association between selected single nucleotide polymorphisms (SNPs)—rs1800797 and rs2069845 in IL-6 and rs2227307 in IL-8—and BC development, as well as to identify the impact of BC on the level of expression and methylation of IL-6 and IL-8 promoters in PBMCs with the use of the TaqMan SNP genotyping assay, TaqMan gene expression assay, and methylation-sensitive high-resolution melting techniques. We did not find any association between the genotypes and combined genotypes of all studied polymorphisms and the occurrence of BC. However, we found that BC patients were characterised by decreased IL-6 and IL-8 mRNA expression levels compared to the controls. Additionally, the methylation status of the IL-6 promoter was higher in controls than in BC patients. Our findings suggest that inflammation may be involved in the development and progression of BC. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Agomelatine Changed the Expression and Methylation Status of Inflammatory Genes in Blood and Brain Structures of Male Wistar Rats after Chronic Mild Stress Procedure.
- Author
-
Bialek, Katarzyna, Czarny, Piotr, Wigner, Paulina, Synowiec, Ewelina, Kolodziej, Lukasz, Bijak, Michal, Szemraj, Janusz, Papp, Mariusz, and Sliwinski, Tomasz
- Subjects
PSYCHOLOGICAL stress ,BRAIN anatomy ,LABORATORY rats ,MONONUCLEAR leukocytes ,P16 gene ,METHYLATION - Abstract
The preclinical research conducted so far suggest that depression development may be influenced by the inflammatory pathways both at the periphery and within the central nervous system. Furthermore, inflammation is considered to be strongly connected with antidepressant treatment resistance. Thus, this study explores whether the chronic mild stress (CMS) procedure and agomelatine treatment induce changes in TGFA, TGFB, IRF1, PTGS2 and IKBKB expression and methylation status in peripheral blood mononuclear cells (PBMCs) and in the brain structures of rats. Adult male Wistar rats were subjected to the CMS and further divided into matched subgroups to receive vehicle or agomelatine. TaqMan gene expression assay and methylation-sensitive high-resolution melting (MS-HRM) were used to evaluate the expression of the genes and the methylation status of their promoters, respectively. Our findings confirm that both CMS and antidepressant agomelatine treatment influenced the expression level and methylation status of the promoter region of investigated genes in PBMCs and the brain. What is more, the present study showed that response to either stress stimuli or agomelatine differed between brain structures. Concluding, our results indicate that TGFA, TGFB, PTGS2, IRF1 and IKBKB could be associated with depression and its treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Clinical Potential of Fruit in Bladder Cancer Prevention and Treatment.
- Author
-
Wigner, Paulina, Bijak, Michał, and Saluk-Bijak, Joanna
- Abstract
Bladder cancer (BC) is the most common tumor of the urinary system in the world. Moreover, despite using anticancer therapies, BC is also characterized by a high recurrence risk. Among numerous risk factors, cigarette smoking, occupational exposure to certain aromatic compounds, and genetic factors contribute most strongly to BC development. However, the epidemiological data to date suggests that diet quality may influence some carcinogenic factors of BC and, therefore, might have a preventative effect. Adequate consumption of selected fruits with scientifically proven properties, including pomegranates and cranberries, can significantly reduce the risk of developing BC, even in those at risk. Therefore, in this article, we aim to elucidate, using available literature, the role of fruits, including pomegranates, cranberries, citrus fruits, cactus pears, and apples, in BC prevention and treatment. Previous data indicate the role of compounds in the above-mentioned fruits in the modulation of the signaling pathways, including cell proliferation, cell growth, cell survival, and cell death. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Effects of venlafaxine on the expression level and methylation status of genes involved in oxidative stress in rats exposed to a chronic mild stress.
- Author
-
Wigner, Paulina, Synowiec, Ewelina, Czarny, Piotr, Bijak, Michal, Jóźwiak, Paweł, Szemraj, Janusz, Gruca, Piotr, Papp, Mariusz, and Śliwiński, Tomasz
- Subjects
OXIDATIVE stress ,CEREBRAL cortex ,METHYLATION ,BASAL ganglia ,DNA methylation - Abstract
Recent human and animal studies indicate that oxidative and nitrosative stress may play a role in the aetiology and pathogenesis of depression. This study investigates the effect of chronic administration of the serotonin‐norepinephrine reuptake inhibitor, venlafaxine, on the expression and methylation status of SOD1, SOD2, GPx1, GPx4, CAT, NOS1 and NOS2 in the brain and blood of rats exposed to a chronic mild stress (CMS) model of depression. Separate groups of animals were exposed to CMS for 2 or 7 weeks; the second group received saline or venlafaxine (10 mg/kg/d, IP) for 5 weeks. After completion of both stress conditions and drug administration, the mRNA and protein expression of selected genes and the methylation status of their promoters were measured in peripheral mononuclear blood cells (PBMCs) and in brain structures (hippocampus, amygdala, hypothalamus, midbrain, cortex, basal ganglia) with the use of TaqMan Gene Expression Assay, Western blot and methylation‐sensitive high‐resolution melting techniques. CMS caused a decrease in sucrose consumption, and this effect was normalized by fluoxetine. In PBMCs, SOD1, SOD2 and NOS2 mRNA expression changed only after venlafaxine administration. In brain, CAT, Gpx1, Gpx4 and NOS1 gene expression changed following CMS or venlafaxine exposure, most prominently in the hippocampus, midbrain and basal ganglia. CMS increased the methylation of the Gpx1 promoter in PBMCs, the second Gpx4 promoter in midbrain and basal ganglia, and SOD1 and SOD2 in hippocampus. The CMS animals treated with venlafaxine displayed a significantly higher CAT level in midbrain and cerebral cortex. CMS caused an elevation of Gpx4 in the hippocampus, which was lowered in cerebral cortex by venlafaxine. The results indicate that CMS and venlafaxine administration affect the methylation of promoters of genes involved in oxidative and nitrosative stress. They also indicate that peripheral and central tissue differ in their response to stress or antidepressant treatments. It is possible that that apart from DNA methylation, a crucial role of expression level of genes may be played by other forms of epigenetic regulation, such as histone modification or microRNA interference. These findings provide strong evidence for thesis that analysis of the level of mRNA and protein expression as well as the status of promoter methylation can help in understanding the pathomechanisms of mental diseases, including depression, and the mechanisms of action of drugs effective in their therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
16. Mitochondrial DNA copy number, damage, repair and degradation in depressive disorder.
- Author
-
Czarny, Piotr, Wigner, Paulina, Strycharz, Justyna, Swiderska, Ewa, Synowiec, Ewelina, Szatkowska, Magdalena, Sliwinska, Agnieszka, Talarowska, Monika, Szemraj, Janusz, Su, Kuan-Pin, Maes, Michael, Sliwinski, Tomasz, and Galecki, Piotr
- Subjects
- *
MITOCHONDRIAL DNA , *MENTAL depression , *HYDROGEN peroxide , *BLOOD cells , *OXIDATIVE stress - Abstract
Objectives: We aimed to explore mitochondrial DNA (mtDNA) copy number, damage, repair and degradation in peripheral blood mononuclear cells (PBMCs) of patients with depression and to compare the results with healthy subjects. Methods: Total genomic DNA was isolated from PBMCs of 25 depressed and 60 healthy subjects before, immediately after, and 3 h after the exposure to H2O2. Evaluation of mtDNA copy number was performed using real-time PCR and 2-ΔCt methods. Semi-long run real-time PCR was used to estimate the number of mtDNA lesions. Results: Baseline mtDNA copy number did not differ in cells of healthy and depressed subjects; however, it was negatively correlated with the severity of the episode. After a 10-min challenge with hydrogen peroxide (H2O2), depressed patients' PBMCs exhibited slower changes of the copy number, indicating a lower efficiency of mtDNA degradation compared to controls. Moreover, a significantly higher number of mtDNA lesions was found in depressed patients at the baseline as well as at other experimental time points. mtDNA lesions were also elevated in depressed patient cells immediately after H2O2 exposure. Induction of oxidative stress had no significant influence on the cells of controls. Conclusions: We are the first to show that impairment in repair and degradation of mtDNA may be involved in the pathophysiology of depression. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. Novel association between TGFA, TGFB1, IRF1, PTGS2 and IKBKB single-nucleotide polymorphisms and occurrence, severity and treatment response of major depressive disorder.
- Author
-
Bialek, Katarzyna, Czarny, Piotr, Watala, Cezary, Wigner, Paulina, Talarowska, Monika, Galecki, Piotr, Szemraj, Janusz, and Sliwinski, Tomasz
- Subjects
MENTAL depression ,SEROTONIN uptake inhibitors ,SINGLE nucleotide polymorphisms ,THERAPEUTICS ,EMOTIONAL conditioning - Abstract
Background: Activation of the immune system might affect the severity of depressive episodes as well as response to the antidepressant treatment. The purpose of this study was to investigate whether the occurrence of variant alleles of analyzed SNPs are involved in prevalence and progression of depression. Moreover, selected genes and SNPs have not been investigated in context of the disease severity and treatment. Therefore, six polymorphisms were selected: g.41354391A>G-TGFB1 (rs1800469), g.132484229C>A-IRF (rs2070729), g.186643058A>G-PTGS2 (rs5275), g.186640617C>T-PTGS2 (rs4648308), g.70677994G>A-TGFA (rs2166975) and g.42140549G>T-IKBKB (rs5029748). Methods: A total of 360 (180 patients and 180 controls) DNA samples were genotyped using TaqMan probes. Results: We observed that A/G of the rs2166975 TGFA, A/C of rs2070729 IRF1 and G/T of rs5029748 IKBKB were associated with an increased risk of depression development while the T/T of rs5029748 IKBKB, T/T of rs4648308 PTGS2 and G/G of rs2166975 TGFA reduced this risk. We also stratified the study group according to gender and found that genotype A/G and allele G of the rs2166975 TGFA, G/T of rs5029748 IKBKB as well as C allele of rs4648308 PTGS2, homozygote A/A and allele A of rs5275 PTGS2 were associated with increased risk of depression development in men while homozygote G/G of rs5275 PTGS2 decreased this risk. Moreover, C/T of rs4648308 PTGS2 and A/G of rs5275 PTGS2 was positively correlated with the risk of the disease occurrence in women. Furthermore, a gene-gene analysis revealed a link between studied polymorphisms and depression. In addition, A/A of rs1800469 TGFB1 was associated with earlier age of onset of the disease while G/G of this SNP increased severity of the depressive episode. Interestingly, A/C of rs2070729 IRF1 and T/T of rs5029748 IKBKB may modulate the effectiveness of selective serotonin reuptake inhibitors therapy. In conclusion, studied SNPs may modulate the risk of occurrence, age of onset, severity of the disease and response to the antidepressant treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
18. EVALUATION OF THE EFFECTS OF EXTREMELY LOW FREQUENCY ELECTROMAGNETIC FIELD ON THE LEVELS OF SOME INFLAMMATORY CYTOKINES IN POST-STROKE PATIENTS.
- Author
-
CICHON, Natalia, SALUK-BIJAK, Joanna, MILLER, Elzbieta, SLIWINSKI, Tomasz, SYNOWIEC, Ewelina, WIGNER, Paulina, and BIJAK, Michal
- Published
- 2019
- Full Text
- View/download PDF
19. Variation of genes encoding KAT1, AADAT and IDO1 as a potential risk of depression development.
- Author
-
Wigner, Paulina, Czarny, Piotr, Synowiec, Ewelina, Bijak, Michał, Talarowska, Monika, Galecki, Piotr, Szemraj, Janusz, and Sliwinski, Tomasz
- Subjects
- *
MENTAL depression risk factors , *GENOTYPES , *SINGLE nucleotide polymorphisms , *DNA analysis , *BLOOD testing , *SEROTONIN uptake inhibitors - Abstract
Numerous data suggests that the disorders of tryptophan catabolites (TRYCATs) pathway, including a decreased level of tryptophan or evaluated concentration of harmful TRYCATs −kynurenine, quinolinic acid, 3-hydroxyanthranilic acid, 3-hydroxytryptophan − may cause the occurrence of DD symptoms. In this work, we assessed the relationship between single-nucleotide polymorphisms (SNPs) of KAT1, KAT2 and IDO1 gene encoding, and the risk of depression development. Our study was performed on the DNA isolated from peripheral blood of 281 depressed patients and 236 controls. We genotyped, by using TaqMan probes, four polymorphisms: c.*456G > A of KAT1 (rs10988134), c.975-7T > C of AADAT (rs1480544), c.-1849C > A (rs3824259) and c.-1493G > C(rs10089084)of IDO1. We found that only the A/A genotype of c.*456G > A − KAT1 (rs10988134) increased the risk of depression occurrence. Interestingly, when we stratified the study group according to gender, this relationship was present only in male population. However, a gene–gene analysis revealed a link between the T/T-C/C genotype of c.975-7T > C − AADAT (rs1480544)or c.-1493G > C − IDO1 (rs10089084) and C/C-C/A genotype of c.975-7T > C − AADAT (rs1480544)and c. −1849C > A − IDO1 (rs3824259) and the disease. Moreover, we found, that the c.975-7T > C − AADAT and c. *456G > A KAT1 (rs10988134) polymorphisms may modulate the effectiveness of selective serotonin reuptake inhibitors therapy. Concluding, our results confirm the hypothesis formulated in our recently published article that the SNPs of genes involved in TRYCATs pathway may modulate the risk of depression. This provides some further evidence that the pathway plays the crucial role in development of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
20. Single-nucleotide polymorphisms of uracil-processing genes affect the occurrence and the onset of recurrent depressive disorder.
- Author
-
Czarny, Piotr, Wigner, Paulina, Strycharz, Justyna, Watala, Cezary, Swiderska, Ewa, Synowiec, Ewelina, Galecki, Piotr, Talarowska, Monika, Szemraj, Janusz, Kuan-Pin Su, and Sliwinski, Tomasz
- Subjects
SINGLE nucleotide polymorphisms ,MENTAL depression ,GENES ,DNA repair ,DNA damage ,GLYCOSYLASES - Abstract
Depressive disorders (DD) are known to be associated with increased DNA damage, the impairment of DNA damage repair, and the presence of single-nucleotide polymorphisms (SNPs) in DNA damage repair genes. Some indirect evidence also suggests that uracil metabolism may be disrupted in depressed patients. Therefore, the current study genotypes three SNPs localized in genes encoding uracil-processing proteins: two glycosylases, i.e., UNG g.7245G>C (rs34259), SMUG1 c.-31A>G (rs3087404), and dUTPase, i.e., DUT g.48638795G>T (rs4775748). The polymorphisms were analyzed in 585 DNA samples (282 cases and 303 controls) using TaqMan probes. The G/G genotype and G allele of UNG polymorphism decreased the risk of depression, while the G/C genotype and C allele of the same SNP increased it. It was also found that G/G carriers had their first episode significantly later than the heterozygotes. Although there was no association between the occurrence of depression and the SMUG1 SNP, a significant difference was found between the homozygotes regarding the onset of DD. In conclusion, the SNPs localized in the uracil-processing genes may modulate the occurrence and the onset of depression, which further supports the hypothesis that impairment of DNA damage repair, especially base-excision repair, may play an important role in the pathogenesis of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
21. Variation of genes involved in oxidative and nitrosative stresses in depression.
- Author
-
Wigner, Paulina, Czarny, Piotr, Synowiec, Ewelina, Bijak, Michał, Białek, Katarzyna, Talarowska, Monika, Galecki, Piotr, Szemraj, Janusz, and Sliwinski, Tomasz
- Subjects
- *
MENTAL depression genetics , *OXIDATIVE stress , *SINGLE nucleotide polymorphisms , *GENETIC code , *BLOOD collection - Abstract
The dominating hypothesis among numerous hypotheses explaining the pathogenesis of depressive disorders (DD) is the one involving oxidative and nitrosative stress. In this study, we examined the association between single-nucleotide polymorphisms of the genes encoding SOD2 (superoxide dismutase 2), CAT (catalase), GPx4 (glutathione peroxidase 4), NOS1 (nitric oxide synthase 1), NOS2 (nitric oxide synthase 2), and the development of depressive disorders. Our study was carried out on the DNA isolated from peripheral blood collected from 281 depressed patients and 229 controls. Using TaqMan probes, we genotyped the following six polymorphisms: c.47T > C (p.Val16Ala) (rs4880) in SOD2 , c.-89A > T (rs7943316) in CAT , c.660T > C (rs713041) in GPx4 , c.-420-34221G > A (rs1879417) in NOS1 , c.1823C > T (p.Ser608Leu) (rs2297518), and c.-227G > C (rs10459953) in NOS2 . We found that the T/T genotype of the c.47T > C polymorphism was linked with an increased risk of depression. Moreover, the T/T genotype and T allele of c.660T > C increased the risk of DD occurrence, while the heterozygote and C allele decreased this risk. On the other hand, we discovered that the A/A genotype of c.-89A > T SNP was associated with a reduced risk of DD, while the A/T genotype increased this risk. We did not find any correlation between the genotypes/alleles of c.-420-34221G > A, c.1823C > T, and c.-227G > C, and the occurrence of DD. In addition, gene-gene and haplotype analyses revealed that combined genotypes and haplotypes were connected with the disease. Moreover, we found that sex influenced the impact of some SNPs on the risk of depression. Concluding, the studied polymorphisms of SOD2, CAT and GPx4 may modulate the risk of depression. These results support the hypothesis that oxidative and nitrosative stresses are involved in the pathogenesis of depressive disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
22. OXIDATIVE AND NITROSATIVE STRESS AS WELL AS THE TRYPTOPHAN CATABOLITES PATHWAY IN DEPRESSIVE DISORDERS.
- Author
-
Wigner, Paulina, Czarny, Piotr, Galecki, Piotr, and Sliwinski, Tomasz
- Published
- 2017
- Full Text
- View/download PDF
23. The Relationship Between Single-Nucleotide Polymorphisms, the Expression of DNA Damage Response Genes, and Hepatocellular Carcinoma in a Polish Population.
- Author
-
Krupa, Renata, Czarny, Piotr, Wigner, Paulina, Wozny, Joanna, Jablkowski, Maciej, Kordek, Radzislaw, Szemraj, Janusz, and Sliwinski, Tomasz
- Subjects
SINGLE nucleotide polymorphisms ,DNA damage ,LIVER cancer ,HEPATITIS B virus ,OXIDATIVE stress ,GENE expression ,CANCER cells - Abstract
The molecular mechanism of hepatocellular carcinoma (HCC) is related to DNA damage caused by oxidative stress products induced by hepatitis B virus (HBV) or C (HCV) infection and exposure to environmental pollutants. Single-nucleotide polymorphisms (SNPs) of DNA damage response (DDR) genes may influence individual susceptibility to environmental risk factors and affect DNA repair efficacy, which, in turn, can influence the risk of HCC. The study evaluates a panel of 15 SNPs in 11 DDR genes ( XRCC1, XRCC3, XPD, MUTYH, LIG1, LIG3, hOGG1, PARP1, NFIL1, FEN1, and APEX1) in 65 HCC patients, 50 HBV- and 50 HCV-infected non-cancerous patients, and 50 healthy controls. It also estimates the mRNA expression of nine DDR genes in cancerous and adjacent healthy liver tissues. Two of the investigated polymorphisms (rs1052133 and rs13181) were associated with HCC risk. For all investigated genes, the level of mRNA was significantly lower in HCC cancer tissue than in non-cancerous liver tissue. Seven of the investigated polymorphisms were statistically related to gene expression in cancer tissues. The disruption of DDR genes may be responsible for hepatocellular transformation in HCV-infected patients. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
24. Probiotics in the Prevention of the Calcium Oxalate Urolithiasis.
- Author
-
Wigner, Paulina, Bijak, Michał, and Saluk-Bijak, Joanna
- Subjects
- *
URINARY calculi , *CALCIUM oxalate , *RENAL colic , *KIDNEY stones , *URINARY organ diseases , *BIFIDOBACTERIUM , *PROBIOTICS - Abstract
Nephrolithiasis ranks third among urological diseases in terms of prevalence, making up about 15% of cases. The continued increase in the incidence of nephrolithiasis is most probably due to changes in eating habits (high protein, sodium, and sugar diets) and lifestyle (reduced physical activity) in all developed countries. Some 80% of all kidney stones cases are oxalate urolithiasis, which is also characterized by the highest risk of recurrence. Frequent relapses of nephrolithiasis contribute to severe complications and high treatment costs. Unfortunately, there is no known effective way to prevent urolithiasis at present. In cases of diet-related urolithiasis, dietary changes may prevent recurrence. However, in some patients, the condition is unrelated to diet; in such cases, there is evidence to support the use of stone-related medications. Interestingly, a growing body of evidence indicates the potential of the microbiome to reduce the risk of developing renal colic. Previous studies have primarily focused on the use of Oxalobacterformigenes in patients with urolithiasis. Unfortunately, this bacterium is not an ideal probiotic due to its antibiotic sensitivity and low pH. Therefore, subsequent studies sought to find bacteria which are capable of oxalate degradation, focusing on well-known probiotics including Lactobacillus and Bifidobacterium strains, Eubacterium lentum, Enterococcus faecalis, and Escherichia coli. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
25. The Green Anti-Cancer Weapon. The Role of Natural Compounds in Bladder Cancer Treatment.
- Author
-
Wigner, Paulina, Bijak, Michal, and Saluk-Bijak, Joanna
- Subjects
- *
BLADDER cancer , *RESVERATROL , *CANCER treatment , *DRUG side effects , *CELL survival , *NATURAL products - Abstract
Bladder cancer (BC) is the second most common genitourinary cancer. In 2018, 550,000 people in the world were diagnosed with BC, and the number of new cases continues to rise. BC is also characterized by high recurrence risk, despite therapies. Although in the last few years, the range of BC therapy has considerably widened, it is associated with severe side effects and the development of drug resistance, which is hampering treatment success. Thus, patients are increasingly choosing products of natural origin as an alternative or complementary therapeutic options. Therefore, in this article, we aim to elucidate, using the available literature, the role of natural substances such as curcumin, sulforaphane, resveratrol, quercetin, 6-gingerol, delphinidin, epigallocatechin-3-gallate and gossypol in the BC treatment. Numerous clinical and preclinical studies point to their role in the modulation of the signaling pathways, such as cell proliferation, cell survival, apoptosis and cell death. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
26. The Molecular Aspect of Nephrolithiasis Development.
- Author
-
Wigner, Paulina, Grębowski, Radosław, Bijak, Michal, Szemraj, Janusz, and Saluk-Bijak, Joanna
- Subjects
- *
URINARY tract infections , *KIDNEY stones , *URINARY organ diseases , *ENZYME deficiency , *LIPID peroxidation (Biology) , *REACTIVE oxygen species , *UREA , *CELL aggregation - Abstract
Urolithiasis is the third most common urological disease after urinary tract infections and prostate diseases, and it is characterised by an occurrence rate of about 15%, which continues to rise. The increase in the incidence of kidney stones observed in recent decades, is most likely caused by modifications in dietary habits (high content of protein, sodium and sugar diet) and lifestyle (reduced physical activity) in all industrialised countries. Moreover, men are more likely than women to be diagnosed with kidney stones. A growing body of evidence suggests that inflammation, oxidant–antioxidant imbalance, angiogenesis, purine metabolism and urea cycle disorders may play a crucial role in nephrolithiasis development. Patients with urolithiasis were characterised by an increased level of reactive oxygen species (ROS), the products of lipid peroxidation, proinflammatory cytokines as well as proangiogenic factors, compared to controls. Furthermore, it has been shown that deficiency and disorders of enzymes involved in purine metabolism and the urea cycle might be causes of deposit formation. ROS generation suggests that the course of kidney stones might be additionally potentiated by inflammation, purine metabolism and the urea cycle. On the other hand, ROS overproduction may induce activation of angiogenesis, and thus, allows deposit aggregation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
27. The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development.
- Author
-
Wigner, Paulina, Grębowski, Radosław, Bijak, Michał, Saluk-Bijak, Joanna, Szemraj, Janusz, and Huttere, Georg C.
- Subjects
- *
BLADDER cancer , *CYSTITIS , *OXIDATIVE stress , *LIPID peroxidation (Biology) , *TOBACCO smoke , *REACTIVE oxygen species - Abstract
In 2018, 550,000 people were diagnosed with bladder cancer (BC), of which nearly 200,000 people died. Moreover, men are 4 times more likely than women to be diagnosed with BC. The risk factors include exposure to environmental and occupational chemicals, especially tobacco smoke, benzidine and genetic factors. Despite numerous studies, the molecular basis of BC development remains unclear. A growing body of evidence suggests that inflammation, oxidant-antioxidant imbalance and angiogenesis disorders may play a significant role in the development and progression of bladder cancer. The patients with bladder cancer were characterised by an increased level of reactive oxygen species (ROS), the products of lipid peroxidation, proinflammatory cytokines and proangiogenic factors as compared to controls. Furthermore, it was shown that polymorphisms localised in genes associated with these pathways may modulate the risk of BC. Interestingly, ROS overproduction may induce the production of proinflammatory cytokines, which finally activated angiogenesis. Moreover, the available literature shows that both inflammation and oxidative stress may lead to activation of angiogenesis and tumour progression in BC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
28. Chronic Mild Stress and Venlafaxine Treatment Were Associated with Altered Expression Level and Methylation Status of New Candidate Inflammatory Genes in PBMCs and Brain Structures of Wistar Rats.
- Author
-
Bialek, Katarzyna, Czarny, Piotr, Wigner, Paulina, Synowiec, Ewelina, Barszczewska, Gabriela, Bijak, Michal, Szemraj, Janusz, Niemczyk, Monika, Tota-Glowczyk, Katarzyna, Papp, Mariusz, Sliwinski, Tomasz, and Centonze, Diego
- Subjects
LABORATORY rats ,PSYCHOLOGICAL stress ,MONONUCLEAR leukocytes ,P16 gene ,VENLAFAXINE ,METHYLATION ,NEUROENDOCRINE cells - Abstract
Preclinical studies conducted to date suggest that depression could be elicited by the elevated expression of proinflammatory molecules: these play a key role in the mediation of neurochemical, neuroendocrine and behavioral changes. Thus, this study investigates the effect of chronic mild stress (CMS) and administration of venlafaxine (SSRI) on the expression and methylation status of new target inflammatory genes: TGFA, TGFB, IRF1, PTGS2 and IKBKB, in peripheral blood mononuclear cells (PMBCs) and in selected brain structures of rats. Adult male Wistar rats were subjected to the CMS and further divided into matched subgroups to receive vehicle or venlafaxine. TaqMan gene expression assay and methylation-sensitive high-resolution melting (MS-HRM) were used to evaluate the expression of the genes and the methylation status of their promoters, respectively. Our results indicate that both CMS and chronic treatment with venlafaxine were associated with changes in expression of the studied genes and their promoter methylation status in PMBCs and the brain. Moreover, the effect of antidepressant administration clearly differed between brain structures. Summarizing, our results confirm at least a partial association between TGFA, TGFB, IRF1, PTGS2 and IKBKB and depressive disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
29. Single-Nucleotide Polymorphisms in Oxidative Stress-Related Genes and the Risk of a Stroke in a Polish Population—A Preliminary Study.
- Author
-
Synowiec, Ewelina, Wigner, Paulina, Cichon, Natalia, Watala, Cezary, Czarny, Piotr, Saluk-Bijak, Joanna, Miller, Elzbieta, Sliwinski, Tomasz, Zielinska-Nowak, Ewa, Bijak, Michal, Zoccolotti, Pierluigi, Meloni, Bruno, and Meriney, Stephen D.
- Subjects
- *
SINGLE nucleotide polymorphisms , *GENES , *ALLELES , *ISCHEMIC stroke , *CD54 antigen - Abstract
The present preliminary case-control study was undertaken to detect the potential association of six single nucleotide polymorphisms (SNPs) in oxidative stress-related genes: SOD2 (c.47T > C; rs4880), CAT (c.-89A > T; rs7943316), GPX4 (c.660T > A; rs713041), NOS1 (g.117803515C > T; rs1879417) and NOS2 (c.1823C > T; rs2297518 and c.-227G > C; rs10459953) and the occurrence of a stroke. The SNPs were determined using the TaqMan® Allelic Discrimination Assay in 107 patients with strokes and 107 age- and sex-matched individuals who had not experienced cerebrovascular accidents. The T alleles of the rs4880 were positively correlated with a stroke (bootstrap OR 1.31; 1.07–1.59 95% CI). In the case of the rs713041, an association with the T allele was found (bootstrap OR 1.36; 1.12–1.67). In addition, the occurrence of a stroke was associated with the presence of the C allele of the rs1879417 (bootstrap OR 1.32; 1.09–1.61). We also found that the C/C genotype and C allele of the rs2297518 increased the risk of a stroke (bootstrap ORs 7.00; 4.34–11.29 and 4.96; 3.88–6.34, respectively). Moreover, the C allele of the rs10459953 was associated with an increased occurrence of this disease (bootstrap OR 1.31; 1.08–1.60). These results indicated that genetics variants in the SOD2, GPX4, NOS1 and NOS2 might be associated with susceptibility to strokes in the Polish population. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
30. The Effect of Chronic Mild Stress and Escitalopram on the Expression and Methylation Levels of Genes Involved in the Oxidative and Nitrosative Stresses as Well as Tryptophan Catabolites Pathway in the Blood and Brain Structures.
- Author
-
Wigner, Paulina, Synowiec, Ewelina, Jóźwiak, Paweł, Czarny, Piotr, Bijak, Michał, Białek, Katarzyna, Szemraj, Janusz, Gruca, Piotr, Papp, Mariusz, and Śliwiński, Tomasz
- Subjects
- *
TRYPTOPHAN , *ESCITALOPRAM , *OXIDATIVE stress , *METHYLATION , *CEREBRAL cortex , *REACTIVE oxygen species , *AMYGDALOID body - Abstract
Previous studies suggest that depression may be associated with reactive oxygen species overproduction and disorders of the tryptophan catabolites pathway. Moreover, one-third of patients do not respond to conventional pharmacotherapy. Therefore, the study investigates the molecular effect of escitalopram on the expression of Cat, Gpx1/4, Nos1/2, Tph1/2, Ido1, Kmo, and Kynu and promoter methylation in the hippocampus, amygdala, cerebral cortex, and blood of rats exposed to CMS (chronic mild stress). The animals were exposed to CMS for two or seven weeks followed by escitalopram treatment for five weeks. The mRNA and protein expression of the genes were analysed using the TaqMan Gene Expression Assay and Western blotting, while the methylation was determined using methylation-sensitive high-resolution melting. The CMS caused an increase of Gpx1 and Nos1 mRNA expression in the hippocampus, which was normalised by escitalopram administration. Moreover, Tph1 and Tph2 mRNA expression in the cerebral cortex was increased in stressed rats after escitalopram therapy. The methylation status of the Cat promoter was decreased in the hippocampus and cerebral cortex of the rats after escitalopram therapy. The Gpx4 protein levels were decreased following escitalopram compared to the stressed/saline group. It appears that CMS and escitalopram influence the expression and methylation of the studied genes. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
31. The Impact of Chronic Mild Stress and Agomelatine Treatment on the Expression Level and Methylation Status of Genes Involved in Tryptophan Catabolic Pathway in PBMCs and Brain Structures.
- Author
-
Wigner, Paulina, Synowiec, Ewelina, Jóźwiak, Paweł, Czarny, Piotr, Białek, Katarzyna, Bijak, Michal, Szemraj, Janusz, Gruca, Piotr, Papp, Mariusz, and Sliwinski, Tomasz
- Subjects
- *
TRYPTOPHAN , *METHYLATION , *CEREBRAL cortex , *BASAL ganglia , *GENES , *AMYGDALOID body , *MESSENGER RNA - Abstract
Depression is the serious mental disorder. Previous studies suggest that the development mechanism of depression may be associated with disorders of the tryptophan catabolic pathway (TRYCAT). Thus, this study investigates the effect of agomelatine treatment on the expression and methylation status of genes involved in TRYCAT in the brain and blood of rats exposed to a chronic mild stress (CMS). Separate groups of rats were exposed to CMS for two or seven weeks; the second group received vehicle or agomelatine for five weeks. After completion of both stress conditions and treatment, the expression levels of messenger RNA (mRNA) and protein, as well as the methylation status of promoters, were measured in peripheral blood mononuclear cells (PBMCs) and in brain structures with the use of TaqMan Gene Expression Assay, Western blot, and methylation-sensitive high-resolution melting techniques. In PBMCs, Kmo mRNA expression increased in the group after CMS, while this effect was normalized by agomelatine therapy. In brain, KatI and KatII expression changed following CMS exposure. Moreover, CMS decreased the methylation status of the second Tdo2 promoter in the amygdala. Protein expression of Tph1, Tph2, Ido1, and KatII changed in the group after CMS and agomelatine administration, most prominently in the basal ganglia, cerebral cortex, hippocampus, and amygdala. The results indicate that CMS and agomelatine affect the mRNA and protein expression, as well as the methylation of promoters of genes involved in the tryptophan catabolic pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
32. The Changes of Expression and Methylation of Genes Involved in Oxidative Stress in Course of Chronic Mild Stress and Antidepressant Therapy with Agomelatine.
- Author
-
Wigner, Paulina, Synowiec, Ewelina, Jóźwiak, Paweł, Czarny, Piotr, Bijak, Michał, Barszczewska, Gabriela, Białek, Katarzyna, Szemraj, Janusz, Gruca, Piotr, Papp, Mariusz, and Śliwiński, Tomasz
- Subjects
- *
OXIDATIVE stress , *GENE expression , *CEREBRAL cortex , *P16 gene , *PROTEIN expression , *ANTIDEPRESSANTS - Abstract
Preclinical studies conducted so far suggest that oxidative stress processes may be associated with the mechanism of depression development. This study shows the effects of chronic administration of agomelatine on expression and the methylation status of Sod1, Sod2, Gpx1, Gpx4, Cat, Nos1, and Nos2 in the brain stricture and blood in the chronic mild stress (CMS) animal model of depression. The animals were exposed to the CMS procedure and treatment with agomelatine (10 mg/kg/day, IP) for five weeks and then were sacrificed. TaqMan Gene Expression Assay, Western blot, and methylation-sensitive high-resolution melting techniques were used to evaluate mRNA and protein expression of the genes, and the methylation status of their promoters. Gpx1, Gpx4, and Sod2 expression in the PBMCs and Sod1 and Sod2 expression in the brain were reduced in the stressed group after agomelatine administration. CMS caused an increase in the methylation of the third Gpx4 promoter in peripheral blood mononuclear cells and Gpx1 promoter in the cerebral cortex. Additionally, stressed rats treated with agomelatine displayed a significantly lower Gpx4 level in the hypothalamus. The results confirm the hypothesis that the CMS procedure and agomelatine administration change the expression level and methylation status of the promoter region of genes involved in oxidative and nitrosative stress. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
33. Variation of Genes Encoding Tryptophan Catabolites Pathway Enzymes in Stroke.
- Author
-
Wigner, Paulina, Saluk-Bijak, Joanna, Synowiec, Ewelina, Miller, Elzbieta, Sliwinski, Tomasz, Cichon, Natalia, and Bijak, Michal
- Subjects
- *
TRYPTOPHAN , *STROKE , *CEREBROVASCULAR disease , *PATHOLOGY , *ENZYMES , *GENES - Abstract
The abnormal activation of the tryptophan catabolites pathway (TRYCATs) is observed in patients suffering from cerebrovascular disease, including stroke. A previous study confirmed that lower bioavailability of tryptophan for serotonin synthesis was characterized in the patients during the acute stroke phase. Interestingly, according to various studies, polymorphisms of the genes involved in the TRYCATs pathway may modulate the risk of stroke occurrence. Therefore, this study aimed to investigate the association between the occurrence of TPH1, TPH2, KAT1, KAT2 and IDO1 polymorphisms and the risk of stroke development.The following 10 polymorphisms of the genes encoding enzymes of the TRYCATs pathway were selected: c.804-7C > A (rs10488682), c.-1668T > A (rs623580), c.803+221C > A (rs1800532), c.-173A > T (rs1799913) – TPH1, c.-1449C > A (rs7963803), and c.-844G > T (rs4570625) – TPH2. c.*456G > A of KAT1 (rs10988134), c.975-7T > C of KAT2 (rs1480544), c.-1849C > A (rs3824259) and c. -1493G > C (rs10089084) of IDO1. The study was carried out on DNA isolated from the peripheral blood taken from 107 patients after a stroke and 107 healthy volunteers. All DNA samples were genotyped using TaqMan probes. The genotypes of eight studied polymorphisms modulated the risk of stroke. No significant difference in genotype and allele frequencies of the c.804-7C > A –TPH1 (rs10488682) and c.*456G > A – KAT1 (rs10988134) polymorphisms were found between patients and controls. Having performed haplotype and gen-gen analyses, it was possible to determine that patients after a stroke and controls differed in terms of the frequency of selected genotypes and haplotypes. Among the studied polymorphisms, eight SNPs were linked with stroke risk modulation. The results obtained confirmed our hypothesis regarding the involvement of the TRYCATs pathway in the pathogenesis of stroke. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
34. The levels of 7,8-dihydrodeoxyguanosine (8-oxoG) and 8-oxoguanine DNA glycosylase 1 (OGG1) – A potential diagnostic biomarkers of Alzheimer's disease.
- Author
-
Sliwinska, Agnieszka, Kwiatkowski, Dominik, Czarny, Piotr, Toma, Monika, Wigner, Paulina, Drzewoski, Jozef, Fabianowska-Majewska, Krystyna, Szemraj, Janusz, Maes, Michael, Galecki, Piotr, and Sliwinski, Tomasz
- Subjects
- *
DEOXYGUANOSINE , *DNA glycosylases , *BIOMARKERS , *ALZHEIMER'S disease , *DNA damage - Abstract
Evidence indicates that oxidative stress contributes to neuronal cell death in Alzheimer's disease (AD). Increased oxidative DNA damage l, as measured with 8-oxoguanine (8-oxoG), and reduced capacity of proteins responsible for removing of DNA damage, including 8-oxoguanine DNA glycosylase 1 (OGG1), were detected in brains of AD patients. In the present study we assessed peripheral blood biomarkers of oxidative DNA damage, i.e. 8- oxoG and OGG1, in AD diagnosis, by comparing their levels between the patients and the controls. Our study was performed on DNA and serum isolated from peripheral blood taken from 100 AD patients and 110 controls. For 8-oxoG ELISA was employed. The OGG1 level was determined using ELISA and Western blot technique. Levels of 8-oxoG were significantly higher in DNA of AD patients. Both ELISA and Western blot showed decreased levels of OGG1 in serum of AD patients. Our results show that oxidative DNA damage biomarkers detected in peripheral tissue could reflect the changes occurring in the brain of patients with AD. These results also suggest that peripheral blood samples may be useful to measure oxidative stress biomarkers in AD. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
35. The Effect of Chronic Mild Stress and Escitalopram on the Expression and Methylation Levels of Genes Involved in the Oxidative and Nitrosative Stresses as Well as Tryptophan Catabolites Pathway in the Blood and Brain Structures.
- Author
-
Wigner P, Synowiec E, Jóźwiak P, Czarny P, Bijak M, Białek K, Szemraj J, Gruca P, Papp M, and Śliwiński T
- Subjects
- Animals, Antidepressive Agents, Second-Generation pharmacology, Brain metabolism, Catalase genetics, Catalase metabolism, Chronic Disease, Depression genetics, Depression metabolism, Glutathione Peroxidase genetics, Glutathione Peroxidase metabolism, Leukocytes, Mononuclear drug effects, Leukocytes, Mononuclear metabolism, Male, Nitric Oxide Synthase Type I genetics, Nitric Oxide Synthase Type I metabolism, Nitrosative Stress, Oxidative Stress, Rats, Wistar, Tryptophan Hydroxylase genetics, Tryptophan Hydroxylase metabolism, Glutathione Peroxidase GPX1, Brain drug effects, Citalopram pharmacology, DNA Methylation drug effects, Gene Expression Regulation drug effects, Metabolic Networks and Pathways genetics, Stress, Psychological physiopathology, Tryptophan metabolism
- Abstract
Previous studies suggest that depression may be associated with reactive oxygen species overproduction and disorders of the tryptophan catabolites pathway. Moreover, one-third of patients do not respond to conventional pharmacotherapy. Therefore, the study investigates the molecular effect of escitalopram on the expression of Cat , Gpx1/4 , Nos1/2 , Tph1/2 , Ido1 , Kmo , and Kynu and promoter methylation in the hippocampus, amygdala, cerebral cortex, and blood of rats exposed to CMS (chronic mild stress). The animals were exposed to CMS for two or seven weeks followed by escitalopram treatment for five weeks. The mRNA and protein expression of the genes were analysed using the TaqMan Gene Expression Assay and Western blotting, while the methylation was determined using methylation-sensitive high-resolution melting. The CMS caused an increase of Gpx1 and Nos1 mRNA expression in the hippocampus, which was normalised by escitalopram administration. Moreover, Tph1 and Tph2 mRNA expression in the cerebral cortex was increased in stressed rats after escitalopram therapy. The methylation status of the Cat promoter was decreased in the hippocampus and cerebral cortex of the rats after escitalopram therapy. The Gpx4 protein levels were decreased following escitalopram compared to the stressed/saline group. It appears that CMS and escitalopram influence the expression and methylation of the studied genes.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.